Back to User profile » Dr Caicun Zhou
Papers published by Dr Caicun Zhou:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Third-Generation TKI Resistance Due to SCLC Transformation: A Case Report and Brief Review
Chen S, He Y, Liu J, Chen X, Yu J, Li W, Chen B, Sun C, Zhou C
OncoTargets and Therapy 2019, 12:11305-11311
Published Date: 19 December 2019
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
OX40 (CD134) and OX40 ligand, important immune checkpoints in cancer
Deng J, Zhao S, Zhang X, Jia K, Wang H, Zhou C, He Y
OncoTargets and Therapy 2019, 12:7347-7353
Published Date: 6 September 2019
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Afatinib versus gemcitabine/cisplatin for first-line treatment of Chinese patients with advanced non-small-cell lung cancer harboring EGFR mutations: subgroup analysis of the LUX-Lung 6 trial
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/IIG8Om9qlkc/1.jpg)
Wu YL, Xu CR, Hu CP, Feng J, Lu S, Huang Y, Li W, Hou M, Shi JH, Märten A, Fan J, Peil B, Zhou C
OncoTargets and Therapy 2018, 11:8575-8587
Published Date: 30 November 2018
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/PrlTJItshQo/1.jpg)
Lu S, Li W, Zhou C, Hu CP, Qin S, Cheng G, Feng J, Wang J, Cseh A, Peil B, Gibson N, Ehrnrooth E, Zhang L
OncoTargets and Therapy 2018, 11:8565-8573
Published Date: 30 November 2018